林雯, 姚静欣, 李正娟. 母胎界面调节性T细胞的来源初步探索[J]. 循证医学, 2020, 20(6): 363-373. DOI: 10.12019/j.issn.1671-5144.2020.06.009
    引用本文: 林雯, 姚静欣, 李正娟. 母胎界面调节性T细胞的来源初步探索[J]. 循证医学, 2020, 20(6): 363-373. DOI: 10.12019/j.issn.1671-5144.2020.06.009
    LIN Wen, YAO Jing-xin, LI Zheng-juan. Preliminary Study of the Source of Regulatory T Cells at the Maternal-Fetal Interface[J]. Journal of Evidence-Based Medicine, 2020, 20(6): 363-373. DOI: 10.12019/j.issn.1671-5144.2020.06.009
    Citation: LIN Wen, YAO Jing-xin, LI Zheng-juan. Preliminary Study of the Source of Regulatory T Cells at the Maternal-Fetal Interface[J]. Journal of Evidence-Based Medicine, 2020, 20(6): 363-373. DOI: 10.12019/j.issn.1671-5144.2020.06.009

    母胎界面调节性T细胞的来源初步探索

    Preliminary Study of the Source of Regulatory T Cells at the Maternal-Fetal Interface

    • 摘要: 目的 探索母胎界面调节性T(regulatory T cells,Treg)细胞的来源及机制。 方法 收集不同孕期(妊娠第0天为E0,以此类推E4.5、E7.5、E10.5、E13.5、E16.5、E19.5)小鼠的胸腺、外周血、脾脏、淋巴结和蜕膜,利用流式细胞术检测各组织中CD4+Foxp3+ Treg细胞占CD4+ T细胞的比例。实时荧光定量聚合酶链反应(real-time quantitative polymerase chain reaction,RT-PCR)和Western blot检测未孕及孕鼠E13.5的子宫蜕膜组织中趋化因子CCL2、CCL7、CCL12及CCL20在mRNA和蛋白的表达水平。流式检测未孕及E13.5孕鼠外周血中Treg细胞表面趋化因子受体CCR2和CCR6的表达。趋化实验检测CCL2、CCL7、CCL12及CCL20对E13.5孕鼠的脾脏中Treg细胞的趋化作用。 结果 同/异基因配对组孕鼠胸腺的Treg细胞在E10.5和E13.5较未孕组增多,但两者之间无差异;而异基因配对组孕鼠蜕膜的Treg细胞占CD4+ T细胞的比例都明显高于同基因配对组,在E10.5达到高峰,并都高于未孕组。而同/异基因配对E13.5两组孕鼠子宫蜕膜中CCL2、CCL12、CCL20的mRNA和蛋白表达水平较未孕组均明显升高,且异基因配对E13.5组明显高于同基因配对E13.5组;而CCL7在mRNA水平的表达升高但在蛋白水平无差异。同/异基因配对E13.5组孕鼠外周血中Treg细胞表面CCR2和CCR6的表达较未孕组均显著升高;CCL2、CCL7、CCL12、CCL20均对妊娠期Treg细胞有明显的趋化作用。 结论 母胎界面的Treg细胞可能主要来源于胸腺,并可通过趋化作用到达蜕膜。

       

      Abstract: Objective To investigate the sources and mechanisms of regulatory T cells at the maternal-fetal interface. Methods Thymus, peripheral blood, spleen, lymph nodes and deciduas were harvested from different pregnancy periods (E0 for embryonic day 0, E4.5, E7.5, E10.5, E13.5, E16.5, E19.5)mice. The proportion of CD4+Foxp3+ Treg cells among CD4+ T cells in each sample was determined by flow cytometry. Real-time quantitative polymerase chain reaction (RT-PCR) and Western blot were used to detect the mRNA and protein expression level of chemokines (CCL2, CCL7, CCL12 and CCL20) in uterine and decidua of non-pregnant and E13.5 mice. Expression of CCR2 and CCR6 in Treg cells of peripheral blood of non-pregnant and E13.5 mice were tested by flow cytometry. Their chemotaxis to Treg cells during pregnancy was assessed by an in vitro chemotaxis assay in a transwell chamber. Results Compared to non-pregnant mice, the proportion of Treg cells in CD4+ T cells in thymus from syngeneic and allogeneic pregnant group was increased at E10.5 and E13.5, but there was no difference between them. The proportion of Treg cells in CD4+ T cells of allogeneic pregnant mice increased significantly and was higher than syngeneic pregnant group, while reached a peak at E10.5. Treg cells of both the two pregnant groups were higher than normal non-pregnant mice. The mRNA and protein expression level of CCL2, CCL12 and CCL20 in uterine and decidua of E13.5 pregnant mice were increased to non-pregnant mice, but the increase of CCL7 occurred in mRNA not protein. The expression of CCR2 and CCR6 in the surface of Treg cells in peripheral blood significantly enhanced in syngeneic and allogeneic pregnant group than non-pregnant one. CCL2, CCL7, CCL12, CCL20 exerted obvious chemotaxis on Treg cells during pregnancy. Conclusions Thymus maybe the main sources of Treg cells at the maternal-fetal interface and Treg cells arrived there by chemotaxis.

       

    /

    返回文章
    返回